Oxford Cannabinoid Techn... Share Discussion Threads

[isis] 08/5/2024 21:16

It seems pretty lame to blame the Stockmarket for losses incurred by this Company since inception. The CEO does not really have to do anything except give updates and sign off an RNS, the Secretary and Accountants take care of that and in anycase they still have to report and account for what they are doing to existing shareholders and Companies House.
Load of BLX that!

[isis] 08/5/2024 17:59

They've blown nearly £20m in 4 years with virtually no revenue. In fact each year got much worse, no wonder they're delisting!

[isis] 08/5/2024 17:45

They've been burning Cash like Bob Marley used to burn Spliff's as far as I can make out!

Financial Highlights

-- Robust balance sheet, debt-free with cash reserves of approximately GBP2.3m at year-end (30 April 2022: GBP9.2m). Cash is forecast to be fully utilised by April 2024.

-- Cash absorbed by operations of GBP7.0m (FY2022: GBP5.4m); Loss for year of GBP5.9m (30 April 2022: GBP4.7m).

-- Basic and diluted loss per share of (0.62p) (30 April 2022: 0.49p loss).
-- Cost savings continued, including closure of London office in April 2022, expected to generate savings of approximately GBP130k p.a.

-- Research costs (excluding salary costs) increased in line with budget to GBP4.3m (30 April 2022: GBP2.9m), of which GBP2.0m relates to OCT461201 and GBP1.9m on OCT130401. A further GBP0.4m was spent on Programmes 3 and 4 mainly relating to the development of CB1/CB2 agonists by Dalriada .

-- Operational costs increased from GBP2.3m to GBP2.7m, including salaries and associated costs of GBP1.4m.

-- Exceptional items of GBP0.1m (30 April 2022: GBP0.3m) relate to share based (non-cash) payment charges. R&D tax credit in the period of GBP1.1m (30 April 2022: GBP0.8m), with tax losses surrendered for the R&D tax credit payment.

[isis] 08/5/2024 17:27

This Company is wailing about being undervalued and leaving the Markets but issuing a Billion Shares a couple of months ago to raise £640k does not exactly show they were in a good financial position.

[revell40] 08/5/2024 17:19

There must be someone out there that will buy this cheap

[zxie] 08/5/2024 08:56

Hi toes More people know you idiots

[bibdaddy] 08/5/2024 07:20

This market is terrible.....we sell our shares due to this rns....they carry on trading make a huge announcement and guess who's bought our shares.....the directors!!! Could be worse it could be Bidstack!

[paulhopeful] 24/4/2024 16:30

Good to see a lord on the board, and the return of volume.. Chocks away.

[sep800] 24/4/2024 14:11

there's been blocks of buys recently, MM's keeping this down to fill thee large orders.
This will take off as soon as the order books have been filled.
Great opportunity considering recent placing 0.5p

[bibdaddy] 24/4/2024 13:33

16.5 million buy trade just gone through and a stack of buying in general today. Let's hope for a leak

[paulhopeful] 20/4/2024 22:55

Is that the placing shares finished? Double bottom! And a 10,000,000 buy. Think this will start to move now.

[sep800] 11/4/2024 21:47

This BB has died !
Where's our expert Burton1 gone ?

Still confused ref last fund raise and allocated shares/ratio

[bibdaddy] 02/4/2024 13:46

When are we expecting more news regarding trials?

[jambam] 28/2/2024 17:47

Out of her depth imo

[jambam] 28/2/2024 17:47

Lost confidence with Clarissa long time ago. Nothing but bs from her

[sep800] 28/2/2024 17:41

Not great news with major share holders reducing their stake.

CEO.... we are losing confidence here !

[burtond1] 26/2/2024 14:05

Director Dealings. Raise was at .5 remember https://www.londonstockexchange.com/news-article/OCTP/directors-dealings/16349345

[sep800] 26/2/2024 13:40

burtond1

where have you disappeared too!